Longitudinal NGAL and cystatin C plasma profiles present a high level of heterogeneity in a mixed ICU population

Abstract Background NGAL and Cystatin C (CysC) as biomarkers for the early detection of AKI are subject to both pathophysiological, as well as patient related heterogeneity. The aim of this study was to investigate the timeline of plasma levels of NGAL and CysC during the first seven days of ICU adm...

Full description

Bibliographic Details
Main Authors: Daniela Jou-Valencia, Meint Volbeda, Jan G. Zijlstra, Jenny E Kootstra-Ros, Jill Moser, Matijs van Meurs, Jacqueline Koeze
Format: Article
Language:English
Published: BMC 2024-01-01
Series:BMC Nephrology
Subjects:
Online Access:https://doi.org/10.1186/s12882-024-03477-2
_version_ 1797275580086878208
author Daniela Jou-Valencia
Meint Volbeda
Jan G. Zijlstra
Jenny E Kootstra-Ros
Jill Moser
Matijs van Meurs
Jacqueline Koeze
author_facet Daniela Jou-Valencia
Meint Volbeda
Jan G. Zijlstra
Jenny E Kootstra-Ros
Jill Moser
Matijs van Meurs
Jacqueline Koeze
author_sort Daniela Jou-Valencia
collection DOAJ
description Abstract Background NGAL and Cystatin C (CysC) as biomarkers for the early detection of AKI are subject to both pathophysiological, as well as patient related heterogeneity. The aim of this study was to investigate the timeline of plasma levels of NGAL and CysC during the first seven days of ICU admission in a mixed ICU population and to relate these to AKI severity during ICU stay. Via these means we aimed to bring clarity to the previously reported heterogeneity of these renal biomarkers. Methods Prospective Observation Cohort. Consecutive patients admitted to adult ICU at an academic hospital in the Netherlands between 18-02-2014 and 31-03-2014 were included. Urine output, serum creatinine, plasma NGAL and CysC were recorded during the first seven days of ICU admission. Biomarker expression was analyzed based on KDIGO score and time of AKI diagnosis. Results 335 patients were included, 110 met KDIGO criteria for AKI. NGAL and CysC plasma levels were higher in AKI patients compared to non-AKI, high variability in individual values resulted in 56% of AKI patients having a false negative, and 32% of non-AKI patients having a false positive. Individual biomarker levels were variable, and no pattern based on KDIGO score was observed. Conclusions Plasma NGAL and CysC as biomarkers for the early AKI detection may be subject to pathophysiological, and patient related heterogeneity. Further understanding of individual biomarker profiles may help in their application amongst mixed ICU populations. Trial Registration The need for informed consent was waived by the Institutional Ethical Review Board of the University Medical Center Groningen (METc 2013 − 174) by Prof. dr. W.A. Kamps on May 17th 2013.
first_indexed 2024-03-07T15:15:33Z
format Article
id doaj.art-dde485fb152b4233821504529e779bfa
institution Directory Open Access Journal
issn 1471-2369
language English
last_indexed 2024-03-07T15:15:33Z
publishDate 2024-01-01
publisher BMC
record_format Article
series BMC Nephrology
spelling doaj.art-dde485fb152b4233821504529e779bfa2024-03-05T17:57:13ZengBMCBMC Nephrology1471-23692024-01-0125111010.1186/s12882-024-03477-2Longitudinal NGAL and cystatin C plasma profiles present a high level of heterogeneity in a mixed ICU populationDaniela Jou-Valencia0Meint Volbeda1Jan G. Zijlstra2Jenny E Kootstra-Ros3Jill Moser4Matijs van Meurs5Jacqueline Koeze6Department of Critical Care, University of Groningen, University Medical Center Groningen (UMCG)Department of Critical Care, University of Groningen, University Medical Center Groningen (UMCG)Department of Critical Care, University of Groningen, University Medical Center Groningen (UMCG)Department of Laboratory Medicine, UMCGDepartment of Critical Care, University of Groningen, University Medical Center Groningen (UMCG)Department of Critical Care, University of Groningen, University Medical Center Groningen (UMCG)Department of Critical Care, University of Groningen, University Medical Center Groningen (UMCG)Abstract Background NGAL and Cystatin C (CysC) as biomarkers for the early detection of AKI are subject to both pathophysiological, as well as patient related heterogeneity. The aim of this study was to investigate the timeline of plasma levels of NGAL and CysC during the first seven days of ICU admission in a mixed ICU population and to relate these to AKI severity during ICU stay. Via these means we aimed to bring clarity to the previously reported heterogeneity of these renal biomarkers. Methods Prospective Observation Cohort. Consecutive patients admitted to adult ICU at an academic hospital in the Netherlands between 18-02-2014 and 31-03-2014 were included. Urine output, serum creatinine, plasma NGAL and CysC were recorded during the first seven days of ICU admission. Biomarker expression was analyzed based on KDIGO score and time of AKI diagnosis. Results 335 patients were included, 110 met KDIGO criteria for AKI. NGAL and CysC plasma levels were higher in AKI patients compared to non-AKI, high variability in individual values resulted in 56% of AKI patients having a false negative, and 32% of non-AKI patients having a false positive. Individual biomarker levels were variable, and no pattern based on KDIGO score was observed. Conclusions Plasma NGAL and CysC as biomarkers for the early AKI detection may be subject to pathophysiological, and patient related heterogeneity. Further understanding of individual biomarker profiles may help in their application amongst mixed ICU populations. Trial Registration The need for informed consent was waived by the Institutional Ethical Review Board of the University Medical Center Groningen (METc 2013 − 174) by Prof. dr. W.A. Kamps on May 17th 2013.https://doi.org/10.1186/s12882-024-03477-2Cystatin CNGALHeterogeneityAKITimeline
spellingShingle Daniela Jou-Valencia
Meint Volbeda
Jan G. Zijlstra
Jenny E Kootstra-Ros
Jill Moser
Matijs van Meurs
Jacqueline Koeze
Longitudinal NGAL and cystatin C plasma profiles present a high level of heterogeneity in a mixed ICU population
BMC Nephrology
Cystatin C
NGAL
Heterogeneity
AKI
Timeline
title Longitudinal NGAL and cystatin C plasma profiles present a high level of heterogeneity in a mixed ICU population
title_full Longitudinal NGAL and cystatin C plasma profiles present a high level of heterogeneity in a mixed ICU population
title_fullStr Longitudinal NGAL and cystatin C plasma profiles present a high level of heterogeneity in a mixed ICU population
title_full_unstemmed Longitudinal NGAL and cystatin C plasma profiles present a high level of heterogeneity in a mixed ICU population
title_short Longitudinal NGAL and cystatin C plasma profiles present a high level of heterogeneity in a mixed ICU population
title_sort longitudinal ngal and cystatin c plasma profiles present a high level of heterogeneity in a mixed icu population
topic Cystatin C
NGAL
Heterogeneity
AKI
Timeline
url https://doi.org/10.1186/s12882-024-03477-2
work_keys_str_mv AT danielajouvalencia longitudinalngalandcystatincplasmaprofilespresentahighlevelofheterogeneityinamixedicupopulation
AT meintvolbeda longitudinalngalandcystatincplasmaprofilespresentahighlevelofheterogeneityinamixedicupopulation
AT jangzijlstra longitudinalngalandcystatincplasmaprofilespresentahighlevelofheterogeneityinamixedicupopulation
AT jennyekootstraros longitudinalngalandcystatincplasmaprofilespresentahighlevelofheterogeneityinamixedicupopulation
AT jillmoser longitudinalngalandcystatincplasmaprofilespresentahighlevelofheterogeneityinamixedicupopulation
AT matijsvanmeurs longitudinalngalandcystatincplasmaprofilespresentahighlevelofheterogeneityinamixedicupopulation
AT jacquelinekoeze longitudinalngalandcystatincplasmaprofilespresentahighlevelofheterogeneityinamixedicupopulation